KORU Medical Systems, Inc.
KRMD
$3.11
$0.134.36%
| Weiss Ratings | KRMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | KRMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | KRMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.64 | |||
| Price History | KRMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -10.12% | |||
| 30-Day Total Return | -25.06% | |||
| 60-Day Total Return | -20.87% | |||
| 90-Day Total Return | 20.54% | |||
| Year to Date Total Return | -19.95% | |||
| 1-Year Total Return | 48.10% | |||
| 2-Year Total Return | -17.94% | |||
| 3-Year Total Return | 2.64% | |||
| 5-Year Total Return | -62.30% | |||
| 52-Week High % Change | -40.99% | |||
| 52-Week Low % Change | 46.08% | |||
| Price | KRMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $5.05 | |||
| 52-Week Low Price | $2.04 | |||
| 52-Week Low Price (Date) | Mar 18, 2024 | |||
| 52-Week High Price (Date) | Feb 04, 2025 | |||
| Valuation | KRMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 136.60M | |||
| Enterprise Value | 132.03M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.26 | |||
| Earnings Per Share Growth | 44.51% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 4.27 | |||
| Price/Book (Q) | 7.70 | |||
| Enterprise Value/Revenue (TTM) | 4.13 | |||
| Price | $3.11 | |||
| Enterprise Value/EBITDA (TTM) | -21.47 | |||
| Enterprise Value/EBIT | -18.72 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | KRMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 45.85M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | KRMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 800 624 9600 | |||
| Address | 100 Corporate Drive Mahwah, NJ 07430 | |||
| Website | www.korumedical.com | |||
| Country | United States | |||
| Year Founded | 1980 | |||
| Profitability | KRMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -22.04% | |||
| Profit Margin | -37.41% | |||
| Management Effectiveness | KRMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -14.05% | |||
| Return on Equity | -- | |||
| Income Statement | KRMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 31.99M | |||
| Total Revenue (TTM) | 31.99M | |||
| Revenue Per Share | $0.70 | |||
| Gross Profit (TTM) | 20.10M | |||
| EBITDA (TTM) | -6.15M | |||
| EBIT (TTM) | -7.05M | |||
| Net Income (TTM) | -11.97M | |||
| Net Income Avl. to Common (TTM) | -11.97M | |||
| Total Revenue Growth (Q YOY) | 16.80% | |||
| Earnings Growth (Q YOY) | -15.53% | |||
| EPS Diluted (TTM) | -0.26 | |||
| EPS Diluted Growth (Q YOY) | -15.00% | |||
| Balance Sheet | KRMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 8.81M | |||
| Cash Per Share (Q) | $0.19 | |||
| Total Current Assets (Q) | 18.93M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 17.73M | |||
| Current Ratio (Q) | 2.993 | |||
| Book Value Per Share (Q) | $0.39 | |||
| Total Assets (Q) | 27.39M | |||
| Total Current Liabilities (Q) | 6.32M | |||
| Total Debt (Q) | 4.24M | |||
| Total Liabilities (Q) | 9.66M | |||
| Total Common Equity (Q) | 17.73M | |||
| Cash Flow | KRMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -1.59M | |||
| Cash from Financing (TTM) | -211.20K | |||
| Net Change in Cash (TTM) | -1.97M | |||
| Levered Free Cash Flow (TTM) | -1.28M | |||
| Cash from Operations (TTM) | -162.50K | |||
